Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report
| Author | Shahnaz Sali | en |
| Author | Masoud Ahmadzad Asl | en |
| Author | Seyed Moayed Alavian | en |
| Author | Shahnaz Sali | en |
| Author | Masoud Ahmadzad Asl | en |
| Author | Seyed Moayed Alavian | en |
| Orcid | Shahnaz Sali [0000-0001-8494-0611] | en |
| Orcid | Seyed Moayed Alavian [0000-0002-4443-6602] | en |
| Issued Date | 2004-06-30 | en |
| Abstract | Aims: In this report we aim to assess therapeutic efficiency and safety of particular brand of IFN-alpha 2b (PDferon B®) in patients with HBeAg negative-CHB in Iran. | en |
| DOI | https://doi.org/ | en |
| Keyword | Hepatitis B | en |
| Keyword | PDferon B | en |
| Keyword | Treatment | en |
| Publisher | Brieflands | en |
| Title | Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report | en |
| Type | Brief Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Alavian2004SaliHBVPDferonIranHepMon.pdf
- Size:
- 18.51 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF